Download PDF
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today launched in Europe the multi-therapy Sapphire™ infusion device at the 18th Congress of the European Association of Hospital Pharmacists (EAHP).

The Sapphire device is a compact and lightweight infusion pump for use in hospitals, home care and ambulatory settings. Device features include the large, intuitive, colour touch-screen, which is designed for easy and quick programming. The Sapphire device's peristaltic pumping system incorporates magnetic flow-control technology and provides low-flow continuity. The pump is designed to deliver medication with a high rate of accuracy during treatment, reduce energy consumption and extend battery life. It includes infusion modes for all intended uses to simplify the patient's care through various clinical areas.

Hospira is launching the Sapphire device in Europe following the company's announcement of an international distribution agreement for the product with Q Core Medical, Ltd. in January. The agreement grants Hospira the right to market and distribute the infusion pump in more than 60 markets. The device is available immediately for order in France, Italy and the UK, with availability in additional European markets to follow. Hospira's leading position in infusion technologies combined with the product strengths of the Sapphire device will benefit infusion pump customers and patients alike. 


"Adding the Sapphire system to the Hospira product portfolio strengthens the breadth of the company's already comprehensive medication management business and reflects the commitment of the company to the devices business. It satisfies a wide range of critical drug delivery needs in ambulatory, hospital and home care environments and readily adapts to emerging needs," commented Svend Andersen, president, Europe, Middle East and Africa,  Hospira. "The agreement to market and distribute the Sapphire device extends Hospira's ability to support patient safety in key geographies around the world." 

EAHP congress attendees are invited to view demonstrations of the Sapphire device at the Hospira stand, number 50 in the congress plan.

«« Eucomed Launches Portal on Market Access in European Countries


Toshiba Unveils Partnership With VUmc to Support Dementia Research »»


Infusion-Pumps

Latest Articles

  • Pharmacist in the ICU

    Pharmacists play a crucial role in the ICU, where patients often require complex medication regimens, including multiple medications and intravenous therapies. The role of a critical care pharmacist is multifaceted and vital to ensuring optimal patient care in the critical care setting.   Cr

    READ MORE
  • Defining Medicines Optimisation in the Intensive Care Unit

      Complex polypharmacy and pathophysiology are common in the intensive care unit (ICU). Medicines optimisation is essential to deliver safe, effective, and individualised pharmacotherapy. This is ideally performed by a specialised ICU pharmacist.   Introduction Medicines ar

    READ MORE
  • Critical Care Pharmacists Save Lives

      The purpose of this review is to discuss the role of critical care pharmacists on the interprofessional healthcare team in the care of critically ill patients and explore current gaps in the provision of comprehensive medication management.   Introduction   “The patient’s

    READ MORE
Infusion-Pumps Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today launched in Europe the multi-therapy Sapphire™ infusion...